bendamustine hydrochloride has been researched along with Cardiomyopathies, Primary in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dhande, P; Girkar, N; Pawar, S; Zaki, S | 1 |
| Boruchov, A; Mulay, S | 1 |
2 other study(ies) available for bendamustine hydrochloride and Cardiomyopathies, Primary
| Article | Year |
|---|---|
Reversible Cardiomyopathy after Rituximab Treatment in a Chronic Lymphocytic Leukemia Patient.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Cardiomyopathies; Cough; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Rituximab | 2022 |
Recurrent and partially reversible cardiomyopathy occurring during treatment with bendamustine and rituximab.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Cardiomyopathies; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphocyte Count; Male; Rituximab | 2015 |